Published in J Biol Chem on January 22, 1999
Cooperation of multiple CCR5 coreceptors is required for infections by human immunodeficiency virus type 1. J Virol (2000) 2.95
CCR5, CXCR4, and CD4 are clustered and closely apposed on microvilli of human macrophages and T cells. J Virol (2001) 1.66
Kinetic factors control efficiencies of cell entry, efficacies of entry inhibitors, and mechanisms of adaptation of human immunodeficiency virus. J Virol (2005) 1.65
Altering expression levels of human immunodeficiency virus type 1 gp120-gp41 affects efficiency but not kinetics of cell-cell fusion. J Virol (2002) 1.29
Cell surface expression of CCR5 and other host factors influence the inhibition of HIV-1 infection of human lymphocytes by CCR5 ligands. Virology (2007) 1.21
HIV-1 infection through the CCR5 receptor is blocked by receptor dimerization. Proc Natl Acad Sci U S A (2000) 1.19
Changes in the V3 region of gp120 contribute to unusually broad coreceptor usage of an HIV-1 isolate from a CCR5 Delta32 heterozygote. Virology (2007) 1.09
Atomic-level mapping of antibody epitopes on a GPCR. J Am Chem Soc (2009) 1.07
Involvement of the second extracellular loop and transmembrane residues of CCR5 in inhibitor binding and HIV-1 fusion: insights into the mechanism of allosteric inhibition. J Mol Biol (2008) 1.04
Analysis of binding sites for the new small-molecule CCR5 antagonist TAK-220 on human CCR5. Antimicrob Agents Chemother (2005) 1.00
An allosteric rheostat in HIV-1 gp120 reduces CCR5 stoichiometry required for membrane fusion and overcomes diverse entry limitations. J Mol Biol (2007) 0.99
Kinetic mechanism for HIV-1 neutralization by antibody 2G12 entails reversible glycan binding that slows cell entry. Proc Natl Acad Sci U S A (2012) 0.97
Identification of a linear peptide recognized by monoclonal antibody 2D7 capable of generating CCR5-specific antibodies with human immunodeficiency virus-neutralizing activity. J Virol (2005) 0.96
The second extracellular loop of CCR5 contains the dominant epitopes for highly potent anti-human immunodeficiency virus monoclonal antibodies. Antimicrob Agents Chemother (2007) 0.94
CD4-independent use of Rhesus CCR5 by human immunodeficiency virus Type 2 implicates an electrostatic interaction between the CCR5 N terminus and the gp120 C4 domain. J Virol (2001) 0.91
Biology and clinical relevance of chemokines and chemokine receptors CXCR4 and CCR5 in human diseases. Exp Biol Med (Maywood) (2011) 0.89
Molecular recognition of CCR5 by an HIV-1 gp120 V3 loop. PLoS One (2014) 0.88
Heterologous Prime-Boost HIV-1 Vaccination Regimens in Pre-Clinical and Clinical Trials. Viruses (2010) 0.86
CCR5 interactions with the variable 3 loop of gp120. J Mol Model (2006) 0.84
Comparative docking study of anibamine as the first natural product CCR5 antagonist in CCR5 homology models. J Chem Inf Model (2009) 0.84
The role of the N-terminal segment of CCR5 in HIV-1 Env-mediated membrane fusion and the mechanism of virus adaptation to CCR5 lacking this segment. Retrovirology (2007) 0.82
Polyvalent AIDS vaccines. Curr HIV Res (2010) 0.82
Reversible and efficient activation of HIV-1 cell entry by a tyrosine-sulfated peptide dissects endocytic entry and inhibitor mechanisms. J Virol (2014) 0.79
Modeling of human CCR5 as target for HIV-I and virtual screening with marine therapeutic compounds. Bioinformation (2008) 0.78
A Multi-Vector, Multi-Envelope HIV-1 Vaccine. J Pediatr Pharmacol Ther (2007) 0.78
HIV-1 vaccine design: harnessing diverse lymphocytes to conquer a diverse pathogen. Hum Vaccin (2009) 0.76
Short Communication: HIV-1 Variants That Use Mouse CCR5 Reveal Critical Interactions of gp120's V3 Crown with CCR5 Extracellular Loop 1. AIDS Res Hum Retroviruses (2015) 0.75
Evolution of coreceptor utilization to escape CCR5 antagonist therapy. Virology (2016) 0.75
Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1. J Virol (1998) 10.94
Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat Genet (1994) 10.14
NAD-dependent inhibition of protein synthesis by Pseudomonas aeruginosa toxin,. Proc Natl Acad Sci U S A (1975) 9.15
Resolution of the early placental mammal radiation using Bayesian phylogenetics. Science (2001) 8.68
Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci U S A (1994) 8.47
Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells. Science (2000) 7.01
Protein methylation in behavioural control mechanisms and in signal transduction. Nature (1979) 6.87
Sensory transduction in Escherichia coli: two complementary pathways of information processing that involve methylated proteins. Proc Natl Acad Sci U S A (1977) 6.63
Capture of an early fusion-active conformation of HIV-1 gp41. Nat Struct Biol (1998) 5.62
A receptor in pituitary and hypothalamus that functions in growth hormone release. Science (1996) 5.45
Cell-surface receptor for ecotropic murine retroviruses is a basic amino-acid transporter. Nature (1991) 4.84
Parallel adaptive radiations in two major clades of placental mammals. Nature (2001) 4.65
Flux coupling in a neuronal glutamate transporter. Nature (1996) 4.43
An excitatory amino-acid transporter with properties of a ligand-gated chloride channel. Nature (1995) 4.14
Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters. Proc Natl Acad Sci U S A (1994) 4.07
Calcium-activated potassium channels expressed from cloned complementary DNAs. Neuron (1992) 4.06
Sensory transduction in Escherichia coli: role of a protein methylation reaction in sensory adaptation. Proc Natl Acad Sci U S A (1977) 3.93
Ion fluxes associated with excitatory amino acid transport. Neuron (1995) 3.76
The surveillance complex interacts with the translation release factors to enhance termination and degrade aberrant mRNAs. Genes Dev (1998) 3.71
Structure-activity relationships of an exotoxin of Pseudomonas aeruginosa. Infect Immun (1977) 3.63
Unexpectedly large size of globin messenger ribonucleic acid. Proc Natl Acad Sci U S A (1971) 3.56
Selective employment of chemokine receptors as human immunodeficiency virus type 1 coreceptors determined by individual amino acids within the envelope V3 loop. J Virol (1997) 3.44
Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex. J Neurosci (1994) 3.34
Simian immunodeficiency virus-specific CD8+ lymphocyte response in acutely infected rhesus monkeys. J Virol (1993) 3.27
Evidence for a glycoprotein "signal" involved in transport between subcellular organelles. Two membrane glycoproteins encoded by murine leukemia virus reach the cell surface at different rates. J Biol Chem (1982) 3.24
Mechanism of action of Pseudomonas aeruginosa exotoxin Aiadenosine diphosphate-ribosylation of mammalian elongation factor 2 in vitro and in vivo. Infect Immun (1977) 3.17
CD4, CXCR-4, and CCR-5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1. J Virol (1997) 3.04
Cooperation of multiple CCR5 coreceptors is required for infections by human immunodeficiency virus type 1. J Virol (2000) 2.95
Kinetics of a human glutamate transporter. Neuron (1995) 2.87
Excitatory amino acid transporter 5, a retinal glutamate transporter coupled to a chloride conductance. Proc Natl Acad Sci U S A (1997) 2.86
In vitro selection and characterization of HIV-1 with reduced susceptibility to PMPA. Antivir Ther (1999) 2.85
Failure of sensory adaptation in bacterial mutants that are defective in a protein methylation reaction. Cell (1978) 2.81
Clinical medical librarianship: the Vanderbilt experience. Bull Med Libr Assoc (1998) 2.80
An endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein. J Virol (1998) 2.73
Molecular cloning of the von Hippel-Lindau tumor suppressor gene and its role in renal carcinoma. Biochim Biophys Acta (1996) 2.64
Cloning, expression, and characterization of the human eosinophil eotaxin receptor. J Exp Med (1996) 2.64
Cloning and characterization of a cell surface receptor for xenotropic and polytropic murine leukemia viruses. Proc Natl Acad Sci U S A (1999) 2.62
Purification and characterization of the Upf1 protein: a factor involved in translation and mRNA degradation. RNA (1995) 2.57
Molecular biology of Friend viral erythroleukemia. Curr Top Microbiol Immunol (1989) 2.52
Macroscopic and microscopic properties of a cloned glutamate transporter/chloride channel. J Neurosci (1998) 2.48
Molecular evidence for multiple origins of Insectivora and for a new order of endemic African insectivore mammals. Proc Natl Acad Sci U S A (1998) 2.44
Multiple ionic conductances of the human dopamine transporter: the actions of dopamine and psychostimulants. J Neurosci (1997) 2.35
Improved methods for purification and assay of eukaryotic messenger ribonucleic acids and ribosomes. Quantitative analysis of their interaction in a fractionated reticulocyte cell-free system. J Biol Chem (1975) 2.30
Synthesis and glycosylation of polyprotein precursors to the internal core proteins of Friend murine leukemia virus. J Virol (1977) 2.26
Isotopic labeling and analysis of phosphoproteins from mammalian ribosomes. Methods Enzymol (1974) 2.19
Dissociation of the CD4 downregulation and viral infectivity enhancement functions of human immunodeficiency virus type 1 Nef. J Virol (1995) 2.17
Role of methionine in bacterial chemotaxis: requirement for tumbling and involvement in information processing. Proc Natl Acad Sci U S A (1975) 2.16
Anomalous origin of the left coronary artery from the pulmonary artery in adults. J Card Surg (1995) 2.16
Using aortic allograft material to treat mycotic aneurysms of the thoracic aorta. Ann Thorac Surg (1996) 2.14
Pleiotropic aspartate taxis and serine taxis mutants of Escherichia coli. J Gen Microbiol (1979) 2.08
Plasma membrane receptors for ecotropic murine retroviruses require a limiting accessory factor. J Virol (1991) 2.05
Nutritional status and clinical outcomes of older patients in rehabilitation. J Hum Nutr Diet (2005) 2.02
Overcoming interference to retroviral superinfection results in amplified expression and transmission of cloned genes. Proc Natl Acad Sci U S A (1988) 2.02
Attractants and repellents control demethylation of methylated chemotaxis proteins in Escherichia coli. Proc Natl Acad Sci U S A (1979) 1.99
Resistance development over 144 weeks in treatment-naive patients receiving tenofovir disoproxil fumarate or stavudine with lamivudine and efavirenz in Study 903. HIV Med (2006) 1.97
Prognostic factors of acute aluminum phosphide poisoning. Indian J Med Sci (2009) 1.94
Molecular evidence regarding the origin of echolocation and flight in bats. Nature (2000) 1.94
Sensory transduction in Escherichia coli: a requirement for methionine in sensory adaptation. Proc Natl Acad Sci U S A (1977) 1.92
Arginine 447 plays a pivotal role in substrate interactions in a neuronal glutamate transporter. J Biol Chem (2000) 1.90
Glycoprotein encoded by the Friend spleen focus-forming virus. J Virol (1979) 1.89
Treatment of bereavement-related major depressive episodes in later life: a controlled study of acute and continuation treatment with nortriptyline and interpersonal psychotherapy. Am J Psychiatry (1999) 1.85
Incidence of atrial flutter/fibrillation in adults with atrial septal defect before and after surgery. Ann Thorac Surg (1999) 1.84
Cloning and expression of a family of inward rectifier potassium channels. Receptors Channels (1994) 1.83
Surgical treatment of active infective aortic valve endocarditis with associated periannular abscess--11 year results. Eur Heart J (2000) 1.82
Circulatory support with pneumatic paracorporeal ventricular assist device in infants and children. Ann Thorac Surg (1998) 1.82
Induction of tyrosine phosphorylation by the erythropoietin receptor correlates with mitogenesis. Mol Cell Biol (1991) 1.81
Blockade of the voltage-gated potassium channel Kv1.3 inhibits immune responses in vivo. J Immunol (1997) 1.80
Ping-pong amplification of a retroviral vector achieves high-level gene expression: human growth hormone production. J Virol (1990) 1.78
Polymorphisms in the CCR5 genes of African green monkeys and mice implicate specific amino acids in infections by simian and human immunodeficiency viruses. J Virol (1997) 1.77
Gene selection in hemoglobin and in antibody-synthesizing cells. Science (1972) 1.76
Preparing librarians to meet the challenges of today's health care environment. J Am Med Inform Assoc (1997) 1.76
Two-site binding of C5a by its receptor: an alternative binding paradigm for G protein-coupled receptors. Proc Natl Acad Sci U S A (1994) 1.73
Attraction by repellents: an error in sensory information processing by bacterial mutants. Science (1978) 1.73
Sensory transduction in Escherichia coli: regulation of the demethylation rate by the CheA protein. Proc Natl Acad Sci U S A (1984) 1.70
Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cells. Eur J Immunol (1997) 1.69
The membrane glycoprotein of Friend spleen focus-forming virus: evidence that the cell surface component is required for pathogenesis and that it binds to a receptor. J Virol (1987) 1.67
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Voltage-gated potassium channels regulate calcium-dependent pathways involved in human T lymphocyte activation. J Exp Med (1993) 1.67
Cloning and expression of a human neutral amino acid transporter with structural similarity to the glutamate transporter gene family. J Biol Chem (1993) 1.66
CCR5, CXCR4, and CD4 are clustered and closely apposed on microvilli of human macrophages and T cells. J Virol (2001) 1.66
Identification and characterization of a widely expressed phosphate transporter/retrovirus receptor family. Kidney Int (1996) 1.66
Isolation of current components and partial reaction cycles in the glial glutamate transporter EAAT2. J Neurosci (2000) 1.65
Cytotoxic T lymphocytes do not appear to select for mutations in an immunodominant epitope of simian immunodeficiency virus gag. J Immunol (1992) 1.65
Characterization of the VHL tumor suppressor gene product: localization, complex formation, and the effect of natural inactivating mutations. Proc Natl Acad Sci U S A (1995) 1.61
Cooperative interactions among subunits of a voltage-dependent potassium channel. Evidence from expression of concatenated cDNAs. J Biol Chem (1992) 1.59
The Sfpi-1 proviral integration site of Friend erythroleukemia encodes the ets-related transcription factor Pu.1. J Virol (1991) 1.58
A sodium-dependent neutral-amino-acid transporter mediates infections of feline and baboon endogenous retroviruses and simian type D retroviruses. J Virol (1999) 1.58
Phosphorylation of ribosomal proteins in rabbit reticulocytes. Characterization and regulatory aspects. Biochemistry (1970) 1.56
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Tethering human immunodeficiency virus type 1 preintegration complexes to target DNA promotes integration at nearby sites. J Virol (1997) 1.56